Clinical Trial

Anesthesia and Cancer Study: Renal Cell Carcinoma

Unknown
View on ClinicalTrials.gov →
Summary
This study investigates the influence of type of anesthesia on recurrence and survival of renal cell carcinoma in patients undergoing nephrectomy. The participants will be allocated to either the group receiving the total intravenous anesthesia (TIVA) using propofol or the group receiving the inhaled anesthetics, such as sevoflurane or desflurane.
Protocol Amendment History 1 change
critical Trial status changed: Active, Not Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT04503148
Lead Sponsor Seoul National University Hospital
Conditions Renal Cell Carcinoma
Enrollment 562 participants
Start Date 2020-09-22
Primary Completion 2022-12-22 (estimated)
Study Completion 2025-12-22 (estimated)
Updated on ClinicalTrials.gov 2024-07-23